{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:09:02Z","timestamp":1793329742403,"version":"4.5.0"},"reference-count":115,"publisher":"Tech Science Press","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.058790","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:11:48Z","timestamp":1740366708000},"page":"1289-1300","source":"Crossref","is-referenced-by-count":7,"title":["Comprehensive review of male breast cancer: Understanding a rare condition"],"prefix":"10.32604","volume":"33","author":[{"given":"ABDUR","family":"JAMIL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RIMSHA","family":"SIDDIQUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FARYAL","family":"ALTAF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIYAL","family":"WARRAICH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FAIZAN","family":"AHMED","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZAHEER","family":"QURESHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/diagnostics11122199","article-title":"Male breast cancer review. A rare case of pure DCIS: imaging protocol, radiomics and management","volume":"11","author":"Tari","year":"2021","journal-title":"Diagnostics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12885-024-11911-9","article-title":"Experiences and perceptions of men following breast cancer diagnosis: a mixed method systematic review","volume":"24","author":"Abboah-Offei","year":"2024","journal-title":"BMC Cancer"},{"key":"ref4","unstructured":"The American Cancer Society. Cancer Facts & Figures 2020. [cited 2024 Dec 21]. Available from: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2020.html."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/ijc.27841","article-title":"An international comparison of male and female breast cancer incidence rates","volume":"132","author":"Ly","year":"2013","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men","volume":"101","author":"Giordano","year":"2004","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-008-0053-y","article-title":"The rising incidence of male breast cancer","volume":"115","author":"Speirs","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref8","unstructured":"American Cancer Society. Key statistics for breast cancer in men; 2024 [cited 2024 Dec 21]. Available from: https:\/\/www.cancer.org\/content\/dam\/cancerorg\/research\/cancer-facts-and-statistics\/breastcancer-facts-and-figures\/2024\/breast-cancer-factsand-figures-2024.pdf."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1734049","DOI":"10.1155\/2022\/1734049","article-title":"Male breast cancer: an updated review of epidemiology, clinicopathology, and treatment","volume":"2022","author":"Zheng","year":"2022","journal-title":"J Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.breast.2020.08.010","article-title":"Epidemiology of male breast cancer","volume":"54","author":"Konduri","year":"2020","journal-title":"The Breast"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"15579883231165626","DOI":"10.1177\/15579883231165626","article-title":"Analysis of knowledge about male breast cancer among patients at tertiary medical center","volume":"17","author":"Altiner","year":"2023","journal-title":"Am J Men\u2019s Health"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1524-4741.2007.00412.x","article-title":"Male breast cancer: a multicentric study","volume":"13","author":"Culell","year":"2007","journal-title":"Breast J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1200\/JCO.2009.25.5729","article-title":"Multidisciplinary meeting on male breast cancer: summary and research recommendations","volume":"28","author":"Korde","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16173049","article-title":"Observational study of men and women with breast cancer in terms of overall survival","author":"Varzaru","year":"2024","journal-title":"Cancers"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-018-4921-9","article-title":"Male breast cancer: A disease distinct from female breast cancer","volume":"173","author":"Gucalp","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4314\/aas.v20i3.2","article-title":"Characteristics and treatment of breast cancer in men: a 12-year single-institution review","volume":"20","author":"Matheka","year":"2023","journal-title":"Ann Afr Surg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"103827","DOI":"10.1016\/j.breast.2024.103827","article-title":"The incidence of male breast cancer in Klinefelter Syndrome and its proposed mechanisms","volume":"78","author":"Cook","year":"2024","journal-title":"Breast"},{"key":"ref18","unstructured":"National Cancer Institute. SEER*Explorer Application. 2021 [cited 2024 Dec 21]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=1&data_type=1&graph_type=2&compareBy=sex&chk_sex_3=3&chk_sex_2=2&rate_type=2&race=1&age_range=1&hdn_stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2#resultsRegion0."},{"key":"ref19","unstructured":"National Cancer Institute. SEER*Explorer. Breast cancer\u2014recent trends in U.S. age-adjusted mortality rates, 2000-2022, by race\/ethnicity, male, all ages. 2024 [cited 2024 Dec 03]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=1&data_type=1&graph_type=2&compareBy=sex&chk_sex_3=3&chk_sex_2=2&rate_type=2&race=1&age_range=1&hdn_stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2#resultsRegion0."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/cam4.2953","article-title":"Delayed presentation, diagnosis, and psychosocial aspects of male breast cancer","volume":"9","author":"Co","year":"2020","journal-title":"Cancer Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e0194651","DOI":"10.1371\/journal.pone.0194651","article-title":"Clinical and ultrasonographic features of male breast tumors: a retrospective analysis","volume":"13","author":"Yuan","year":"2018","journal-title":"PLoS One"},{"key":"ref22","first-page":"810","article-title":"Nipple discharge: an early warning sign of breast cancer","volume":"3","author":"Parthasarathy","year":"2012","journal-title":"Int J Prev Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e13706","DOI":"10.1097\/MD.0000000000013706","article-title":"Axillary lymph node metastasis as the first manifestation of male occult breast cancer","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jbi\/wbac095","article-title":"Breast cancer screening in men","volume":"5","author":"Gao","year":"2023","journal-title":"J Breast Imaging"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/pmed.2001.0999","article-title":"Men\u2019s and women\u2019s knowledge and perceptions of breast cancer and mammography screening","volume":"34","author":"Chamot","year":"2002","journal-title":"Prev Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5152\/tjbh.2015.2565","article-title":"Mammography findings of male breast diseases","volume":"11","author":"Safak","year":"2015","journal-title":"J Breast Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejrad.2012.10.019","article-title":"Value of mammography and breast ultrasound in male patients with nipple discharge","volume":"82","author":"Mu\u00f1oz Carrasco","year":"2013","journal-title":"Eur J Radiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s00330-010-1867-7","article-title":"Mammography and ultrasound in the evaluation of male breast disease","volume":"20","author":"Mu\u00f1oz Carrasco","year":"2010","journal-title":"Eur Radiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ejso.2016.07.144","article-title":"Core needle biopsy for the assessment of unilateral male breast lesions","volume":"43","author":"Bicchierai","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000494486","article-title":"Diagnostic value of fine-needle aspiration in male breast lesions","volume":"63","author":"Hoda","year":"2019","journal-title":"Acta Cytol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2484\/rcr.v6i3.455","article-title":"Male breast carcinoma and the use of MRI","volume":"6","author":"Shaw","year":"2011","journal-title":"Radiol Case Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000501956","article-title":"Male breast cancer patients\u2019 perspectives on their health care situation: a mixed-methods study","volume":"15","author":"Halbach","year":"2020","journal-title":"Breast Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/diagnostics12071554","article-title":"An update on the general features of breast cancer in male patients\u2014a literature review","volume":"12","author":"Ionescu","year":"2022","journal-title":"Diagnostics"},{"key":"ref34","unstructured":"National Cancer Institute. Male breast cancer treatment (PDQ\u00ae): patient version. PDQ cancer information summaries; 2024 [cited 2024 Dec 03]. Available from: https:\/\/www.cancer.gov\/types\/breast\/patient\/malebreast-treatment-pdq."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"CPath.S31563","DOI":"10.4137\/CPath.S31563","article-title":"Diversity of breast carcinoma: histological subtypes and clinical relevance","volume":"8","author":"Makki","year":"2015","journal-title":"Clin Med Insights Pathol"},{"key":"ref36","first-page":"6852","article-title":"Male breast carcinoma: a clinicopathological and immunohistochemical characterization study","volume":"7","author":"Zhou","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00428-006-0305-3","article-title":"Invasive carcinomas of the male breast: A morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases","volume":"449","author":"Burga","year":"2006","journal-title":"Virchows Arch"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr2258","article-title":"Immunohistochemical characterization of subtypes of male breast carcinoma","volume":"11","author":"Ge","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000136825","article-title":"Male breast cancer","volume":"3","author":"Rudlowski","year":"2008","journal-title":"Breast Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/cancers16030548","article-title":"HER2-low expression in male breast cancer: results from a multicenter series in Italy","volume":"16","author":"Silvestri","year":"2024","journal-title":"Cancers"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"New Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Nat Acad Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12032-022-01749-1","article-title":"Molecular perspective on targeted therapy in breast cancer: a review of current status","volume":"39","author":"Demir Cetinkaya","year":"2022","journal-title":"Med Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.3390\/cancers13143535","article-title":"Genetic landscape of male breast cancer","volume":"13","author":"Campos","year":"2021","journal-title":"Cancers"},{"key":"ref45","first-page":"e41737","article-title":"Unveiling the role of hormonal imbalance in breast cancer development: a comprehensive review","volume":"15","author":"Satpathi","year":"2023","journal-title":"Cureus"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.crad.2011.05.004","article-title":"Imaging male breast cancer","volume":"66","author":"Doyle","year":"2011","journal-title":"Clin Radiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/cancers13092085","article-title":"Estrogens in hepatocellular carcinoma: friends or foes?","volume":"13","author":"Carruba","year":"2021","journal-title":"Cancers"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/en.2009-0070","article-title":"Obesity and breast cancer: the estrogen connection","volume":"150","author":"Cleary","year":"2009","journal-title":"Endocrinology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e20224","DOI":"10.1016\/j.heliyon.2023.e20224","article-title":"Estrogens and the risk of breast cancer: a narrative review of literature","volume":"9","author":"Al-Shami","year":"2023","journal-title":"Heliyon"},{"key":"ref50","first-page":"1128","article-title":"Sex hormones in the risk of breast cancer: a two-sample Mendelian randomization study","volume":"13","author":"Ke","year":"2023","journal-title":"Am J Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.maturitas.2015.06.002","article-title":"Testosterone and breast cancer prevention","volume":"82","author":"Glaser","year":"2015","journal-title":"Maturitas"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/djn329","article-title":"Prospective evaluation of risk factors for male breast cancer","volume":"100","author":"Brinton","year":"2008","journal-title":"J Nat Cancer Inst"},{"key":"ref53","article-title":"BRCA1 and BRCA2 mutations and treatment strategies for breast cancer","volume":"4","author":"Godet","year":"2017","journal-title":"Integr Cancer Sci Ther"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai","year":"2007","journal-title":"J Nat Cancer Inst"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0380-x","article-title":"Obesity and male breast cancer: provocative parallels?","volume":"13","author":"Humphries","year":"2015","journal-title":"BMC Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/bcr2930","article-title":"Male breast carcinoma: increased awareness needed","volume":"13","author":"White","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3892\/br.2016.575","article-title":"Occupational exposure and risk of breast cancer","volume":"4","author":"Fenga","year":"2016","journal-title":"Biomed Rep"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.seminoncol.2017.11.002","article-title":"Male breast cancer: epidemiology and risk factors","volume":"44","author":"Abdelwahab Yousef","year":"2017","journal-title":"Semin Oncol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jjco\/hyl095","article-title":"Survival of male breast cancer patients: a population-based study in Osaka","volume":"36","author":"Ioka","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdt025","article-title":"Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship","volume":"24","author":"Ruddy","year":"2013","journal-title":"Ann Oncol"},{"key":"ref61","first-page":"1","article-title":"Estrogen receptors, hormonal imbalance, gynecomastia, hyperestrogenemia, and male breast cancer: a literature review","volume":"20","author":"Pyo","year":"2024","journal-title":"J Mens Health"},{"key":"ref62","unstructured":"CDC. About breast cancer in men | breast cancer | CDC; 2024 [cited 2024 Nov 18]. https:\/\/www.cdc.gov\/breast-cancer\/about\/men.html."},{"key":"ref63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2009.04.003","article-title":"Male breast cancer","volume":"73","author":"Ottini","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/028418601750288181","article-title":"Risk factors for male breast cancer? A case-control study from Scandinavia","volume":"40","author":"Ewertz","year":"2001","journal-title":"Acta Oncol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1651-2227.2010.02131.x","article-title":"Breast cancer risk among patients with Klinefelter syndrome","volume":"100","author":"Brinton","year":"2011","journal-title":"Acta Paediatr"},{"key":"ref66","first-page":"246","article-title":"Carcinoma of the male breast and Klinefelter\u2019s syndrome: is there an association?","volume":"37","author":"Evans","year":"1987","journal-title":"CA Cancer J Clin"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1158\/1078-0432.CCR-16-2552","article-title":"Emerging data and current challenges for young, old, obese, or male patients with breast cancer","volume":"23","author":"Freedman","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref68","first-page":"6918","article-title":"Risk factors for male breast cancer","volume":"15","author":"Fentiman","year":"2023","journal-title":"Am J Transl Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-018-4952-2","article-title":"Surgical options for male breast cancer","volume":"172","author":"Fentiman","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.12659\/AJCR.916947","article-title":"Modified radical mastectomy for male breast cancer","volume":"20","author":"Al Awayshih","year":"2019","journal-title":"Am J Case Rep"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/j.clbc.2019.12.004","article-title":"Breast conserving surgery compared with mastectomy in male breast cancer: a brief systematic review","volume":"20","author":"Sauder","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"ref72","first-page":"e18337","article-title":"Male breast cancer: treatment trends, reported outcomes, and suggested recommendations","volume":"13","author":"Arzanova","year":"2021","journal-title":"Cureus"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3390\/cancers12123645","article-title":"Adjuvant radiation therapy for male breast cancer\u2014a rare indication?","volume":"12","author":"Forster","year":"2020","journal-title":"Cancers"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/1097-0142(19891015)64:8<1583::AID-CNCR2820640804>3.0.CO;2-Q","article-title":"Role of adjuvant chemotherapy in male breast cancer","volume":"64","author":"Patel","year":"1989","journal-title":"Cancer"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3747\/co.v17i5.631","article-title":"Endocrine therapy for male breast cancer: Rates of toxicity and adherence","volume":"17","author":"Visram","year":"2010","journal-title":"Curr Oncol"},{"key":"ref76","article-title":"Tamoxifen","author":"Farrar","year":"2023 Apr 10","journal-title":"StatPearls"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","article-title":"Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer","volume":"23","author":"L\u00f8nning","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","article-title":"Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17","volume":"24","author":"Perez","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1074\/mcp.R400001-MCP200","article-title":"Targeted therapy in breast cancer: the HER-2\/neu gene and protein","volume":"3","author":"Ross","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1470-2045(18)30083-4","article-title":"Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force\/Breast Cancer Group","volume":"19","author":"Wildiers","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/healthcare5020026","article-title":"Breast cancer: exploring the facts and holistic needs during and beyond treatment","volume":"5","author":"Ng","year":"2017","journal-title":"Healthcare"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-7563.2008.00141.x","article-title":"Male breast cancer: progress, prognosis and future pathways","volume":"4","author":"Field","year":"2008","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1245\/s10434-010-1468-3","article-title":"Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration","volume":"18","author":"Gnerlich","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jjco\/hyt116","article-title":"Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences","volume":"43","author":"Chen","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1016\/j.clbc.2018.06.013","article-title":"Male breast cancer: an updated surveillance, epidemiology, and end results data analysis","volume":"18","author":"Liu","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4048\/jbc.2021.24.e54","article-title":"Prognostic factors in male breast cancer: a retrospective nationwide study in south korea by the study of SMARTSHIP Group","volume":"24","author":"Park","year":"2021","journal-title":"J Breast Cancer"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-016-3768-1","article-title":"Prognostic factors in male breast cancer: a population-based study","volume":"156","author":"Leone","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.breast.2013.02.005","article-title":"The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study","volume":"22","author":"Yu","year":"2013","journal-title":"The Breast"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4103\/jcrt.JCRT_1305_16","article-title":"Male breast cancer: outcome with adjuvant treatment","volume":"16","author":"Yadav","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"e100871","DOI":"10.1136\/gpsych-2022-100871","article-title":"Cancer-related psychosocial challenges","volume":"35","author":"Wang","year":"2022","journal-title":"Gen Psychiat"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"955057","DOI":"10.3389\/fonc.2022.955057","article-title":"Sexual dysfunction as a challenge in treated breast cancer: in-depth analysis and risk assessment to improve individual outcomes","volume":"12","author":"Hern\u00e1ndez-Blanquisett","year":"2022","journal-title":"Front Oncol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"722877","DOI":"10.3389\/fpsyg.2021.722877","article-title":"Gender comparison of psychological reaction between breast cancer survivors and their spouses","volume":"12","author":"Tan","year":"2021","journal-title":"Front Psychol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1177\/1557988318799025","article-title":"Men with a \u201cwoman\u2019s disease\u201d: stigmatization of male breast cancer patients\u2014a mixed methods analysis","volume":"12","author":"Midding","year":"2018","journal-title":"Am J Mens Health"},{"key":"ref94","first-page":"371","article-title":"Optimal delivery of male breast cancer follow-up care: improving outcomes","volume":"7","author":"Ruddy","year":"2015","journal-title":"Breast Cancer: Target Therapy"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"155798831987000","DOI":"10.1177\/1557988319870001","article-title":"Social support of male breast cancer patients\u2014a mixed-methods analysis","volume":"13","author":"Midding","year":"2019","journal-title":"Am J Mens Health"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/07347332.2010.488140","article-title":"Is there an \u201cideal cancer\u201d support group? Key findings from a qualitative study of three groups","volume":"28","author":"Bell","year":"2010","journal-title":"J Psychosoc Oncol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1477-7525-11-121","article-title":"The benefits of psychosocial interventions for cancer patients undergoing radiotherapy","volume":"11","author":"Guo","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"ref98","first-page":"23","article-title":"Male breast cancer: medical and psychological management in comparison to female breast cancer. A review","volume":"7","author":"da Silva","year":"2016","journal-title":"Cancer Treat Commun"},{"key":"ref99","first-page":"6669","article-title":"Exploring the experiences and psychosocial support needs of informal carers of men with breast cancer: a qualitative study","volume":"30","author":"Herring","year":"2022","journal-title":"Support Care Cancer"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"205510291881531","DOI":"10.1177\/2055102918815318","article-title":"Empowerment from patient\u2019s and caregiver\u2019s perspective in cancer care","volume":"5","author":"Marzorati","year":"2018","journal-title":"Health Psychol Open"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/ajim.ajim_108_21","article-title":"Breast cancer and body image: the roles of the male partner","volume":"11","author":"Akpor","year":"2023","journal-title":"APIK J Intern Med"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/cncr.28469","article-title":"Managing body image difficulties of adult cancer patients: lessons from available research","volume":"120","author":"Fingeret","year":"2014","journal-title":"Cancer"},{"key":"ref103","unstructured":"Ahearn T. PLCO-1423: MERGE: a consortium for male breast cancer genetics\u2014approved projects\u2014the cancer data access system. 2023 [cited 2024 Dec 21]. Available from: https:\/\/cdas.cancer.gov\/approved-projects\/4540\/."},{"key":"ref104","unstructured":"National Cancer Institute. Establishing a new consortium, MERGE, to investigate the genetics of male breast cancer. 2024 [cited 2024 Dec 21]. Available from: https:\/\/epi.grants.cancer.gov\/cohort-consortium\/projecthub\/activeprojects\/project-proposal\/82\/."},{"key":"ref105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/annonc\/mdx651","article-title":"Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG international male breast cancer program","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1634\/theoncologist.2015-0174","article-title":"Male breast cancer: a study in small steps","volume":"20","author":"Korde","year":"2015","journal-title":"Oncologist"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5534\/wjmh.200164","article-title":"Male breast cancer: a comparative analysis from the national cancer database","volume":"39","author":"Elimimian","year":"2020","journal-title":"World J Mens Health"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4174\/astr.2017.92.5.331","article-title":"Next-generation sequencing of BRCA1\/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results","volume":"92","author":"Park","year":"2017","journal-title":"Ann Surg Treat Res"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/diagnostics13071241","article-title":"Liquid biopsy in the management of breast cancer patients: where are we now and where are we going","volume":"13","author":"Mazzitelli","year":"2023","journal-title":"Diagnostics"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.3390\/cancers15225463","article-title":"The diversity of liquid biopsies and their potential in breast cancer management","volume":"15","author":"Keup","year":"2023","journal-title":"Cancers"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11523-021-00796-4","article-title":"An overview of PARP inhibitors for the treatment of breast cancer","volume":"16","author":"Cortesi","year":"2021","journal-title":"Target Oncol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.trecan.2021.05.004","article-title":"Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises","volume":"7","author":"Pham","year":"2021","journal-title":"Trends Cancer"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.annonc.2020.08.2064","article-title":"TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker","volume":"31","author":"Mayer","year":"2020","journal-title":"Ann Oncol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"TPS632","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS632","article-title":"ETHAN: a phase II study comparing different endocrine therapies for male breast cancer","volume":"42","author":"Leone","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamaoncol.2020.7442","article-title":"Efficacy of endocrine therapy for the treatment of breast cancer in men: results from the MALE phase 2 randomized clinical trial","volume":"7","author":"Reinisch","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-6\/OncolRes-33-06-58790\/OncolRes-33-58790.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:33:37Z","timestamp":1763343217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n6\/61337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":115,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.058790","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}